ClinicalTrials.gov record
Recruiting Phase 1Phase 2 Interventional

Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer

ClinicalTrials.gov ID: NCT05563220

Public ClinicalTrials.gov record NCT05563220. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 11:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1b/2, Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer

Study identification

NCT ID
NCT05563220
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Stemline Therapeutics, Inc.
Industry
Enrollment
435 participants

Conditions and interventions

Interventions

  • Abemaciclib Drug
  • Alpelisib Drug
  • Capivasertib Drug
  • Elacestrant Drug
  • Everolimus Drug
  • Palbociclib Drug
  • Ribociclib Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 23, 2023
Primary completion
Dec 26, 2026
Completion
Dec 27, 2028
Last update posted
Jan 5, 2026

2023 – 2028

United States locations

U.S. sites
45
U.S. states
26
U.S. cities
42
Facility City State ZIP Site status
Dothan Hematology and Oncology Dothan Alabama 36303 Recruiting
Mayo Clinic - Arizona Phoenix Arizona 85054 Recruiting
Highlands Oncology Group Springdale Arkansas 72762 Recruiting
OPN Healthcare (Arcadia Location) Arcadia California 91007 Withdrawn
City of Hope National Medical Center Duarte California 91010 Not yet recruiting
Glendale Adventist Glendale California 91206 Withdrawn
OPN Healthcare (Los Alamitos Location) Los Alamitos California 90720 Recruiting
Cedars Sinai Los Angeles California 90048 Recruiting
UCLA UCLA Hem/Onc - Clinical Research Unit Los Angeles California 90095 Recruiting
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94158 Recruiting
TOI Clinical Research Whittier California 90603 Completed
Rocky Mountain Cancer Centers Lone Tree Colorado 80124 Recruiting
Yale School Of Medicine - Smilow Cancer Hospital - Breast Center New Haven Connecticut 06519 Withdrawn
George Washington Cancer Center Washington D.C. District of Columbia 20037 Recruiting
Advent Health (Florida Hospital) - Altamonte Springs Altamonte Springs Florida 32701 Recruiting
Mayo Clinic - Jacksonville Jacksonville Florida 32224 Recruiting
Ocala Oncology Ocala Florida 34474 Withdrawn
Northside Hospital Atlanta Cancer Care Cumming Georgia 30041 Withdrawn
Northwestern Feinberg Scholl of Medicine Prentice Women's Hospital Chicago Illinois 60611 Recruiting
Fort Wayne Medical Oncology and Hematology Fort Wayne Indiana 46804 Withdrawn
MD Alliance for Multispecialty Research, LLC Merriam Kansas 66204 Recruiting
New England Cancer Specialists Scarborough Maine 04074 Withdrawn
Johns Hopkins School of Medicine Baltimore Maryland 21287 Recruiting
Massachusetts General Hospital Boston Massachusetts 02114 Recruiting
Dana Farber Cancer Institute Boston Massachusetts 02215 Recruiting
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201 Recruiting
Minnesota Oncology Hematology Minneapolis Minnesota 55404 Withdrawn
Mayo Clinic - Rochester Rochester Minnesota 55905 Recruiting
Washington University School of Medicine in St. Louis St Louis Missouri 63110 Recruiting
Astera Cancer Care East Brunswick New Jersey 08816 Recruiting
Summit Medical Group Florham Park New Jersey 07932 Recruiting
Cooperman Barnabas Medical Center New Brunswick New Jersey 08901 Recruiting
NYU Langone Health New York New York 10016 Recruiting
New York Cancer and Blood Specialists Port Jefferson Station New York 11776 Withdrawn
W&IH of RI Breast Health Center of Women and Infants Hospital of Rhode Island Providence Rhode Island 02905 Recruiting
Sarah Cannon Research Institute / Tennessee Oncology Nashville Tennessee 37203 Recruiting
Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 Recruiting
MD Anderson Cancer Center Texas Houston Texas 77030 Recruiting
UT Health San Antonio San Antonio Texas 78229 Recruiting
Inova Schar Cancer Institute Fairfax Virginia 22031 Withdrawn
Virginia Cancer Specialists Fairfax Virginia 22031 Recruiting
Virginia Oncology Associates Norfolk Virginia 23502 Recruiting
Cancer Care Northwest Spokane Valley Washington 99216 Recruiting
Northwest Medical Specialties (Nwms) - Puyallup - Medical Oncology (Rainier Hematology-Oncology)/Exigent Research Network; LLC Tacoma Washington 98405 Recruiting
University of WI - Carbone Cancer Center (Phase II only) Madison Wisconsin 53792 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 73 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05563220, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 5, 2026 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05563220 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →